1 Vyxeos Market Overview 1.1 Product Overview and Scope of Vyxeos 1.2 Vyxeos Segment by Type 1.2.1 Global Vyxeos Sales Growth Rate Comparison by Type (2020-2026) 1.2.2 Daunorubicin 29 mg/m2 and Cytarabine 65 mg/m2 1.2.3 Daunorubicin 44 mg/m2 and Cytarabine 100 mg/m2 1.3 Vyxeos Segment by Application 1.3.1 Vyxeos Sales Comparison by Application: (2020-2026) 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Global Vyxeos Market Size Estimates and Forecasts 1.4.1 Global Vyxeos Revenue 2015-2026 1.4.2 Global Vyxeos Sales 2015-2026 1.4.3 Vyxeos Market Size by Region: 2020 Versus 2026 2 Global Vyxeos Market Competition by Manufacturers 2.1 Global Vyxeos Sales Market Share by Manufacturers (2015-2020) 2.2 Global Vyxeos Revenue Share by Manufacturers (2015-2020) 2.3 Global Vyxeos Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Vyxeos Manufacturing Sites, Area Served, Product Type 2.5 Vyxeos Market Competitive Situation and Trends 2.5.1 Vyxeos Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Vyxeos Players (Opinion Leaders) 3 Vyxeos Retrospective Market Scenario by Region 3.1 Global Vyxeos Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Vyxeos Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Vyxeos Market Facts & Figures by Country 3.3.1 North America Vyxeos Sales by Country 3.3.2 North America Vyxeos Sales by Country 3.3.3 the United States 3.3.4 Canada 3.4 Europe Vyxeos Market Facts & Figures by Country 3.4.1 Europe Vyxeos Sales by Country 3.4.2 Europe Vyxeos Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Vyxeos Market Facts & Figures by Region 3.5.1 Asia Pacific Vyxeos Sales by Region 3.5.2 Asia Pacific Vyxeos Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Vyxeos Market Facts & Figures by Country 3.6.1 Latin America Vyxeos Sales by Country 3.6.2 Latin America Vyxeos Sales by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Vyxeos Market Facts & Figures by Country 3.7.1 Middle East and Africa Vyxeos Sales by Country 3.7.2 Middle East and Africa Vyxeos Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Vyxeos Historic Market Analysis by Type 4.1 Global Vyxeos Sales Market Share by Type (2015-2020) 4.2 Global Vyxeos Revenue Market Share by Type (2015-2020) 4.3 Global Vyxeos Price Market Share by Type (2015-2020) 4.4 Global Vyxeos Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Vyxeos Historic Market Analysis by Application 5.1 Global Vyxeos Sales Market Share by Application (2015-2020) 5.2 Global Vyxeos Revenue Market Share by Application (2015-2020) 5.3 Global Vyxeos Price by Application (2015-2020) 6 Company Profiles and Key Figures in Vyxeos Business 6.1 Celator Pharmaceuticals 6.1.1 Corporation Information 6.1.2 Celator Pharmaceuticals Description, Business Overview 6.1.3 Celator Pharmaceuticals Vyxeos Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Celator Pharmaceuticals Products Offered 6.1.5 Celator Pharmaceuticals Recent Development 6.2 Jazz Pharma 6.2.1 Jazz Pharma Corporation Information 6.2.2 Jazz Pharma Description, Business Overview 6.2.3 Jazz Pharma Vyxeos Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Jazz Pharma Products Offered 6.2.5 Jazz Pharma Recent Development 7 Vyxeos Manufacturing Cost Analysis 7.1 Vyxeos Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Vyxeos 7.4 Vyxeos Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Vyxeos Distributors List 8.3 Vyxeos Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Vyxeos Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Vyxeos by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Vyxeos by Type (2021-2026) 10.2 Vyxeos Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Vyxeos by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Vyxeos by Application (2021-2026) 10.3 Vyxeos Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Vyxeos by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Vyxeos by Region (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Vyxeos Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Vyxeos Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Vyxeos Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Vyxeos Manufacturers Covered in This Study Table 5. Global Vyxeos Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Vyxeos Sales Share by Manufacturers (2015-2020) Table 7. Global Vyxeos Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Vyxeos Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Vyxeos Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Vyxeos Sales Sites and Area Served Table 11. Manufacturers Vyxeos Product Types Table 12. Global Vyxeos Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Vyxeos by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vyxeos as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Vyxeos Players Table 16. Global Vyxeos Sales (K Units) by Region (2015-2020) Table 17. Global Vyxeos Sales Market Share by Region (2015-2020) Table 18. Global Vyxeos Revenue (Million US$) by Region (2015-2020) Table 19. Global Vyxeos Revenue Market Share by Region (2015-2020) Table 20. North America Vyxeos Sales by Country (2015-2020) (K Units) Table 21. North America Vyxeos Sales Market Share by Country (2015-2020) Table 22. North America Vyxeos Revenue by Country (2015-2020) (US$ Million) Table 23. North America Vyxeos Revenue Market Share by Country (2015-2020) Table 24. Europe Vyxeos Sales by Country (2015-2020) (K Units) Table 25. Europe Vyxeos Sales Market Share by Country (2015-2020) Table 26. Europe Vyxeos Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Vyxeos Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Vyxeos Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Vyxeos Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Vyxeos Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Vyxeos Revenue Market Share by Region (2015-2020) Table 32. Latin America Vyxeos Sales by Country (2015-2020) (K Units) Table 33. Latin America Vyxeos Sales Market Share by Country (2015-2020) Table 34. Latin America Vyxeos Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Vyxeos Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Vyxeos Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Vyxeos Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Vyxeos Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Vyxeos Revenue Market Share by Country (2015-2020) Table 40. Global Vyxeos Sales (K Units) by Type (2015-2020) Table 41. Global Vyxeos Sales Share by Type (2015-2020) Table 42. Global Vyxeos Revenue (Million US$) by Type (2015-2020) Table 43. Global Vyxeos Revenue Share by Type (2015-2020) Table 44. Global Vyxeos Price (USD/Unit) by Type (2015-2020) Table 45. Global Vyxeos Sales (K Units) by Application (2015-2020) Table 46. Global Vyxeos Sales Market Share by Application (2015-2020) Table 47. Global Vyxeos Sales Growth Rate by Application (2015-2020) Table 48. Celator Pharmaceuticals Corporation Information Table 49. Celator Pharmaceuticals Description and Business Overview Table 50. Celator Pharmaceuticals Vyxeos Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Celator Pharmaceuticals Main Product Table 52. Celator Pharmaceuticals Recent Development Table 53. Jazz Pharma Corporation Information Table 54. Jazz Pharma Description and Business Overview Table 55. Jazz Pharma Vyxeos Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Jazz Pharma Main Product Table 57. Jazz Pharma Recent Development Table 58. Production Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Vyxeos Distributors List Table 61. Vyxeos Customers List Table 62. Vyxeos Market Trends Table 63. Vyxeos Opportunities and Drivers Table 64. Vyxeos Market Challenges Table 65. Global Vyxeos Sales (K Units) Forecast by Type (2021-2026) Table 66. Global Vyxeos Sales Market Share Forecast by Type (2021-2026) Table 67. Global Vyxeos Revenue (Million US$) Forecast by Type (2021-2026) Table 68. Global Vyxeos Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 69. Global Vyxeos Sales (K Units) Forecast by Application (2021-2026) Table 70. Global Vyxeos Revenue (Million US$) Forecast by Application (2021-2026) Table 71. Global Vyxeos Sales (K Units) Forecast by Region (2021-2026) Table 72. Global Vyxeos Sales Market Share Forecast by Region (2021-2026) Table 73. Global Vyxeos Revenue Forecast by Region (2021-2026) (US$ Million) Table 74. Global Vyxeos Revenue Market Share Forecast by Region (2021-2026) Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Vyxeos Figure 2. Global Vyxeos Sales Market Share by Type: 2020 VS 2026 Figure 3. Daunorubicin 29 mg/m2 and Cytarabine 65 mg/m2 Product Picture Figure 4. Daunorubicin 44 mg/m2 and Cytarabine 100 mg/m2 Product Picture Figure 5. Global Vyxeos Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital Figure 7. Pharmacy Figure 8. Global Vyxeos Market Size 2015-2026 (US$ Million) Figure 9. Global Vyxeos Sales Capacity (K Units) (2015-2026) Figure 10. Global Vyxeos Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Vyxeos Sales Share by Manufacturers in 2020 Figure 12. Global Vyxeos Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Vyxeos Revenue in 2019 Figure 14. Vyxeos Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Vyxeos Sales Market Share by Region (2015-2020) Figure 16. Global Vyxeos Sales Market Share by Region in 2019 Figure 17. Global Vyxeos Revenue Market Share by Region (2015-2020) Figure 18. Global Vyxeos Revenue Market Share by Region in 2019 Figure 19. North America Vyxeos Sales Market Share by Country in 2019 Figure 20. North America Vyxeos Revenue Market Share by Country in 2019 Figure 21. the United States Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 22. the United States Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Vyxeos Sales Market Share by Country in 2019 Figure 26. Europe Vyxeos Revenue Market Share by Country in 2019 Figure 27. Germany Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 30. France Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. UK Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 32. UK Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Vyxeos Sales Market Share by Region in 2019 Figure 38. Asia Pacific Vyxeos Revenue Market Share by Region in 2019 Figure 39. China Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 40. China Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 46. India Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Vyxeos Sales Market Share by Country in 2019 Figure 62. Latin America Vyxeos Revenue Market Share by Country in 2019 Figure 63. Mexico Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Vyxeos Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Vyxeos Revenue Market Share by Country in 2019 Figure 71. Turkey Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. UAE Vyxeos Sales Growth Rate (2015-2020) (K Units) Figure 76. UAE Vyxeos Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Vyxeos by Type (2015-2020) Figure 78. Sales Market Share of Vyxeos by Type in 2020 Figure 79. Global Vyxeos Market Share by Price Range (2015-2020) Figure 80. Revenue Market Share of Vyxeos by Type in 2019 Figure 81. Global Vyxeos Sales Growth by Type (2015-2020) (K Units) Figure 82. Sales Market Share of Vyxeos by Application (2015-2020) Figure 83. Sales Market Share of Vyxeos by Application in 2020 Figure 84. Revenue Share of Vyxeos by Application (2015-2020) Figure 85. Revenue Share of Vyxeos by Application in 2020 Figure 86. Key Raw Materials Price Trend Figure 87. Manufacturing Cost Structure of Vyxeos Figure 88. Manufacturing Process Analysis of Vyxeos Figure 89. Vyxeos Industrial Chain Analysis Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Porter's Five Forces Analysis Figure 93. Bottom-up and Top-down Approaches for This Report Figure 94. Data Triangulation Figure 95. Key Executives Interviewed

Celator Pharmaceuticals Jazz Pharma